Non-Current Assets
Software and Technology Licenses, Net
Kailera Therapeutics Software and Technology Licenses, Net increased by 105.5% to $5.59M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryEfficiency
SignalHigher is better
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026May 26, 2026
How to read this metric
An increase suggests ongoing investment in technology and digital capabilities, which can drive long-term operational efficiency.
Detailed definition
This represents the capitalized cost of acquired software and technology licenses, net of accumulated amortization. It r...
Peer comparison
Increasingly important across the restaurant sector as companies invest in mobile apps, kiosks, and data analytics.
Metric ID:
software_technology_licenses_netHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $2.72M | $5.59M |
| QoQ Change | — | +105.5% |
Range$2.72M – $5.59M
Software and Technology Licenses, Net at Other Companies
Frequently Asked Questions
- What is Kailera Therapeutics 's software and technology licenses, net?
- Kailera Therapeutics (KLRA) reported software and technology licenses, net of $5.59M in Q1 2026.
- What does software and technology licenses, net mean?
- The net book value of the company's software and technology licenses.